179 related articles for article (PubMed ID: 12380342)
1. [Adverse effects of NSAID are insidious. No pain--despite life threatening gastric hemorrhage].
MMW Fortschr Med; 2002 Sep; 144(37):55. PubMed ID: 12380342
[No Abstract] [Full Text] [Related]
2. [Progress in therapy of rheumatism. New coxib works especially fast].
MMW Fortschr Med; 2003 Jun; 145(23):58. PubMed ID: 12854230
[No Abstract] [Full Text] [Related]
3. [Pain therapy in rheumatism. After 65 years of age coxibs are the best choice].
MMW Fortschr Med; 2003 Oct; 145(42):60. PubMed ID: 14655447
[No Abstract] [Full Text] [Related]
4. [Tolerable pain therapy in rheumatism saves long-term costs. Despite this most COX-2 candidates receive conventional NSAID therapy].
MMW Fortschr Med; 2003 Jul; 145(29-30):61. PubMed ID: 12958786
[No Abstract] [Full Text] [Related]
5. [Adverse effect-free analgesia. New COX-2 inhibitor is even more selective].
MMW Fortschr Med; 2003 May; 145(18):54. PubMed ID: 12808824
[No Abstract] [Full Text] [Related]
6. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
[TBL] [Abstract][Full Text] [Related]
7. [Current EULAR data on valdecoxib. New study results of gastrointestinal safety and "cost effectiveness"].
Kellner H
Krankenpfl J; 2004; 42(5-6):185. PubMed ID: 15527245
[No Abstract] [Full Text] [Related]
8. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
[No Abstract] [Full Text] [Related]
9. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
10. Right ballpark, wrong base: assessing safety of NSAIDs.
Shaughnessy AF
J Fam Pract; 2002 Jun; 51(6):538. PubMed ID: 12100777
[No Abstract] [Full Text] [Related]
11. [When the cardiac patient with arthritis needs aspirin and NSAID: how to protect the stomach?].
Zeidler H
MMW Fortschr Med; 2003 Jan; 145(5):8. PubMed ID: 12619198
[No Abstract] [Full Text] [Related]
12. Celecoxib for rheumatoid arthritis.
Megeff CE; Strayer SM
J Fam Pract; 2000 Feb; 49(2):108-9. PubMed ID: 10718683
[No Abstract] [Full Text] [Related]
13. Valdecoxib (Bextra)--a new cox-2 inhibitor.
Med Lett Drugs Ther; 2002 Apr; 44(1129):39-40. PubMed ID: 11981510
[No Abstract] [Full Text] [Related]
14. [Every 1000th long-term user dies of gastric complications. What gastric protection for which NSAID patients?].
Stiefelhagen P
MMW Fortschr Med; 2006 Feb; 148(5):11. PubMed ID: 16518929
[No Abstract] [Full Text] [Related]
15. [Coxib instead of NSAID plus gastric acid inhibitor. Protection for the small intestine].
MMW Fortschr Med; 2004 Mar; 146(13):61. PubMed ID: 15219139
[No Abstract] [Full Text] [Related]
16. NSAIDS for prevention? Protecting the brain while killing pain?
Helmuth L
Science; 2002 Aug; 297(5585):1262-3. PubMed ID: 12193765
[No Abstract] [Full Text] [Related]
17. COX-2 inhibitors and the heart: putting risk in perspective.
Bobadilla RV; Barnett EM; Randels CL
Adv Nurse Pract; 2005 Nov; 13(11):48-50. PubMed ID: 16295003
[No Abstract] [Full Text] [Related]
18. [Rapid and safe pain management. Promising new cyclooxygenase inhibitor].
MMW Fortschr Med; 2002 Jul; 144(29-30):53. PubMed ID: 12219614
[No Abstract] [Full Text] [Related]
19. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
20. [Gastrointestinal complications caused by NSAIDs. Over 60% of arthrosis patients are endangered].
MMW Fortschr Med; 2003 Mar; 145(10):60. PubMed ID: 12688036
[No Abstract] [Full Text] [Related]
[Next] [New Search]
